miR-182-5p Inhibits NKAPL Expression and Promotes the Proliferation of Osteosarcoma

被引：0
|
作者：
Shen Yang
Kaixi Chen
Kun Cao
Shenglin Xu
Chengxiao Ma
Yongping Cai
Yong Hu
Yejin Zhou
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Orthopedics
[2] The Third Affiliated Hospital of Anhui Medical University,Department of Orthopedics, The First People’s Hospital of Hefei
[3] The First Affiliated Hospital of Anhui Medical University,Department of Pathology
来源：
Biotechnology and Bioprocess Engineering | 2021年 / 26卷
关键词：
osteosarcoma; miR-182-5p; NKAPL; clinical characteristics; proliferation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：758 / 766
页数：8
相关论文
共 50 条
  • [41] Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
    Barnas, Edyta
    Skret-Magierlo, Joanna Ewa
    Paszek, Sylwia
    Kaznowska, Ewa
    Potocka, Natalia
    Skret, Andrzej
    Sakowicz, Agata
    Zawlik, Izabela
    GENES, 2023, 14 (03)
  • [42] mir-182-5p regulates all three phases of inflammation, proliferation, and remodeling during cutaneous wound healing
    Amjadian, Sara
    Fatemi, Mohammad Javad
    Moradi, Sharif
    Hesaraki, Mahdi
    Mohammadi, Parvaneh
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [43] Correction: Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
    Ahmed Ibrahim AbdElneam
    Mohammed Saleh Al-Dhubaibi
    Saleh Salem Bahaj
    Ghada Farouk Mohammed
    Lina Mohammed Atef
    Archives of Dermatological Research, 317 (1)
  • [44] Inhibitory effect of miR-182-5p on retinal neovascularization by targeting angiogenin and BDNF
    Li, Chenyue
    Lie, Hongxuan
    Sun, Weifeng
    MOLECULAR MEDICINE REPORTS, 2022, 25 (02)
  • [45] Circular RNA MTO1 Inhibits the Proliferation and Invasion of Ovarian Cancer Cells Through the miR-182-5p/KLF15 Axis
    Wang, Ning
    Cao, Qin-Xue
    Tian, Jun
    Ren, Lu
    Cheng, Hai-Ling
    Yang, Shao-Qin
    CELL TRANSPLANTATION, 2020, 29
  • [46] Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
    Weale, Cecil Jack
    Matshazi, Don M.
    Davids, Saarah F. G.
    Raghubeer, Shanel
    Erasmus, Rajiv T.
    Kengne, Andre Pascal
    Davison, Glenda Mary
    Matsha, Tandi E.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 5037 - 5047
  • [47] miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (vol 11, 12, 2018)
    Cao, Man-Qing
    You, A-Bin
    Zhu, Xiao-Dong
    Zhang, Wei
    Zhang, Yuan-Yuan
    Zhang, Shi-Zhe
    Zhang, Kei-wei
    Cai, Hao
    Shi, Wen-Kai
    Li, Xiao-Long
    Li, Kang-Shuai
    Gao, Dong-Mei
    Ma, De-Ning
    Ye, Bo-Gen
    Wang, Cheng-Hao
    Qin, Cheng-Dong
    Sun, Hui-Chan
    Zhang, Ti
    Tang, Zhao-You
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [48] Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
    Sun, Yang
    Su, Sanmao
    Li, Mengjun
    Deng, Ang
    ANALYTICAL CELLULAR PATHOLOGY, 2023, 2023
  • [49] MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T
    Wu, Yucai
    Zhang, Cuijian
    Peng, Ding
    He, Shiming
    Huang, Cong
    Qian, Jinqin
    Zhu, Weijie
    Feng, Ninghan
    Gong, Yanqing
    Li, Xuesong
    Zhou, Liqun
    HUMAN CELL, 2022, 35 (02) : 542 - 556
  • [50] miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1
    Li, Nan
    Nan, Chuan-Chuan
    Zhong, Xue-Yun
    Weng, Jun-Quan
    Fan, Hai-Dong
    Sun, Hai-Peng
    Tang, Su
    Shi, Lei
    Huang, Sheng-Xing
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) : 1329 - 1341
12345